Loading...

Stay current with insights from our analysts and industry updates.  Subscribe to one of our HealthCheck24 newsletters to receive regular weekly insights by email. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.

Addressing Western medtech design bias in emerging markets

Image

08-Jul-15 Emerging markets are the medtech industry’s best prospects for growth, but most medical devices are still designed in the US and Europe. That can present a problem when companies try to adapt devices or develop new devices for non-Western markets, which may have different cultural, financial, and other considerations that can affect the success of a product. [image: University of Minnesota]

Read More

India's Apollo to focus on knee revision surgeries

Image

06-Sep-15 With thousands of knee replacement surgeries performed in India annually, about 10% require revision surgery. In view of the need for revision surgeries, Apollo Hospitals has entered into an understanding with Orthopaedic Clinic Lindenlohe, Germany. Under the agreement, Indian surgeons will get be trained in Germany and a professor from the clinic will visit Apollo Hyderabad twice a year. [image: Money Control]

Read More

Mobile health technologies: Hype or hope for developing countries?

Image

06-Sep-15 mHealth is aiding health in developing countries where traditional healthcare may prevent patients from receiving optimal care. At the Global Forum on Research & Innovation for Health in Manila, the Korean Intl Cooperation Agency said with 6.3 billion mobile subscribers worldwide, 80% from developing countries, health services through mobiles can reach even those with insufficient access to traditional healthcare. [image: Samuel Aranda / Panos]

Read More

Korean medical companies sign 15 MOUs with China

Image

04-Sep-15 Korean medical companies will speed up their entry into China, having secured a bridgehead into the telemedicine market by inking agreements with Chinese partners. Other agreements will allow Korea to export more drugs and biotech to China. These developments will help Korea become one of the top seven healthcare powers within five years. [image: Business Korea]

Read More
Share